UVV Stock Analysis: Universal | NYSE
Tobacco | NYSE, USA | Market Cap: 1.283m USD | 12M Return: 1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.0M
EPS Trend: 23.6%
Rev. Trend: 84.8%
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Universal Corporation (NYSE: UVV) is a Richmond, Virginia-based business-to-business agriproducts company that operates through two segments: Tobacco Operations and Ingredients Operations. The Tobacco Operations segment procures, processes, and packs multiple varieties of leaf tobacco-including flue-cured, burley, dark air-cured, and oriental-and offers value-added services such as custom blending, tobacco testing, reconstituted leaf manufacturing, and liquid nicotine production. The Ingredients Operations segment produces a wide range of specialty plant-based ingredients-such as juices, concentrates, purees, botanical extracts, natural flavors, and colors-for consumer-packaged goods, food, and beverage manufacturers.
Unlike consumer-facing tobacco companies, UVV operates as an upstream B2B supplier, selling processed leaf to cigarette manufacturers rather than retailing tobacco products directly. Its diversification into plant-based ingredients reflects the broader food and beverage industrys growing demand for natural, clean-label, and value-added ingredient solutions sourced from agricultural raw materials.
- Global leaf tobacco demand softens as cigarette volumes decline
- Ingredients segment revenue grows on plant-based food and beverage demand
- FDA regulation and menthol ban proposals pressure leaf tobacco pricing
| Net Income: 32.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -5.94 > 1.0 |
| NWC/Revenue: 48.13% < 20% (prev 47.70%; Δ 0.42% < -1%) |
| CFO/TA 0.05 > 3% & CFO 129.1m > Net Income 32.6m |
| Net Debt (913.2m) to EBITDA (234.0m): 3.90 < 3 |
| Current Ratio: 3.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.2m) vs 12m ago 0.10% < -2% |
| Gross Margin: 17.47% > 18% (prev 18.64%; Δ -1.17% > 0.5%) |
| Asset Turnover: 101.6% > 50% (prev 98.59%; Δ 3.02% > 0%) |
| Interest Coverage Ratio: 2.32 > 6 (EBIT TTM 180.6m / Interest Expense TTM 78.0m) |
| A: 0.51 (Total Current Assets 1.97b - Total Current Liabilities 564.2m) / Total Assets 2.77b |
| B: 0.41 (Retained Earnings 1.14b / Total Assets 2.77b) |
| C: 0.06 (EBIT TTM 180.6m / Avg Total Assets 2.88b) |
| D: 1.08 (Book Value of Equity 1.42b / Total Liabilities 1.31b) |
| Altman-Z'' = 6.24 = AAA |
| DSRI: 0.92 (Receivables 576.2m/633.0m, Revenue 2.92b/2.95b) |
| GMI: 1.07 (GM 18.64% / 17.47%) |
| AQI: 0.98 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 0.99 (Revenue 2.92b / 2.95b) |
| TATA: -0.03 (NI 32.6m - CFO 129.1m) / TA 2.77b) |
| Beneish M = -3.06 (Cap -4..+1) = AA |
As of July 17, 2026, the stock is trading at USD 53.02 with a total of 439,943 shares traded. Over the past week, the price has changed by +4.72%, over one month by +0.48%, over three months by +4.03% and over the past year by +0.99%.
Current recommended Stop Loss: 51.20 (which is 3.4% or 1.8 ATR below the current price).
Universal has no consensus analysts rating.
| Analysts Target Price | 74 | 39.6% |
P/E Trailing = 40.2031
P/E Forward = 12.1212
P/S = 0.4386
P/B = 0.918
P/EG = 4.0411
Revenue TTM = 2.92b USD
EBIT TTM = 180.6m USD
EBITDA TTM = 234.0m USD
Long Term Debt = 616.7m USD (from longTermDebt, last quarter)
Short Term Debt = 298.7m USD (from shortTermDebt, last quarter)
Debt = 975.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 35.5m
Net Debt = 913.2m USD (calculated: Debt 975.4m - CCE 62.2m)
Enterprise Value = 2.20b USD (1.28b + Debt 975.4m - CCE 62.2m)
Interest Coverage Ratio = 2.32 (Ebit TTM 180.6m / Interest Expense TTM 78.0m)
EV/FCF = 27.36x (Enterprise Value 2.20b / FCF TTM 80.3m)
FCF Yield = 3.66% (FCF TTM 80.3m / Enterprise Value 2.20b)
FCF Margin = 2.74% (FCF TTM 80.3m / Revenue TTM 2.92b)
Net Margin = 1.12% (Net Income TTM 32.6m / Revenue TTM 2.92b)
Gross Margin = 17.47% ((Revenue TTM 2.92b - Cost of Revenue TTM 2.41b) / Revenue TTM)
Gross Margin QoQ = 13.77% (prev 18.42%)
Tobins Q-Ratio = 0.79 (Enterprise Value 2.20b / Total Assets 2.77b)
Interest Expense / Debt = 7.99% (Interest Expense 78.0m / Debt 975.4m)
Taxrate = 45.45% (46.7m / 102.7m)
NOPAT = 98.5m (EBIT 180.6m * (1 - 45.45%))
Current Ratio = 3.49 (Total Current Assets 1.97b / Total Current Liabilities 564.2m)
Debt / Equity = 0.69 (Debt 975.4m / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = 3.90 (Net Debt 913.2m / EBITDA 234.0m)
Debt / FCF = 11.38 (Net Debt 913.2m / FCF TTM 80.3m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.13% (Net Income 32.6m / Total Assets 2.77b)
RoE = 2.24% (Net Income TTM 32.6m / Total Stockholder Equity 1.46b)
RoCE = 8.71% (EBIT 180.6m / Capital Employed (Equity 1.46b + L.T.Debt 616.7m))
RoIC = 4.04% (NOPAT 98.5m / Invested Capital 2.44b)
WACC = 5.56% (E(1.28b)/V(2.26b) * Re(6.47%) + D(975.4m)/V(2.26b) * Rd(7.99%) * (1-Tc(0.45)))
Discount Rate = 6.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 39.98 | Cagr: 0.24%
[DCF] Terminal Value 73.10% ; FCFF base≈153.9m ; Y1≈135.0m ; Y5≈109.1m
[DCF] Fair Price = 33.59 (EV 1.75b - Net Debt 913.2m = Equity 837.2m / Shares 24.9m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 23.63 | EPS CAGR: 7.20% | SUE: N/A | # QB: 0
Revenue Correlation: 84.76 | Revenue CAGR: 4.58% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.25 | Chg30d=-26.47% | Revisions=-25% | Analysts=1
EPS next Quarter (2026-09-30): EPS=1.22 | Chg30d=-8.27% | Revisions=-25% | Analysts=1
EPS current Year (2027-03-31): EPS=4.30 | Chg30d=-2.27% | Revisions=-25% | GrowthEPS=+62.9% | GrowthRev=-0.6%
EPS next Year (2028-03-31): EPS=4.38 | Chg30d=-4.99% | Revisions=-25% | GrowthEPS=+1.9% | GrowthRev=+2.0%